Mulet-Pons, L, Solé-Padullés, C, Cabello-Toscano, M, Abellaneda-Pérez, K, Perellón-Alfonso, R, Cattaneo, G, Sánchez, JS, Alviarez-Schulze, V, Bargalló, N, Tormos-Muñoz, JM, Pascual-Leone, A, Bartrés-Faz, D, Vaqué-Alcázar, L. Impact of repetitive negative thinking on subjective cognitive decline: insights into cognition and brain structure. Frontiers in Aging Neuroscience. 2024; 16DOI:10.3389/fnagi.2024.1441359. PMID:39193493. IF:4.500(Q1/2D).

Iñiguez, AE, Peral, ALG, de Teherán, JD, Lasaosa, SS, Godia, EC, Bujanda, MM, Pérez, NR, Juanes, FV, Soblechero, AS, Díez, FI, Fernández, MTT, Baurier, VO, García-Moncó, JC, Arilla, SA, Sánchez, AJ, Mínguez-Olaondo, A, Nieva, AR, Porta-Etessam, J, Zubizarreta, IK, López-Bravo, A, Villanueva, MH, Gago-Viega, A, Oria, CG, López, AA, Sánchez-Mateos, NM, Castrillo, AS, Treviño, C, Sierra-Mencía, A, García, AR, López, JAM, Pérez, MPN, Zorrilla-Lequerica, PM, Escudero, MDA, Ros, AL, Luque, SG, Alvarez, M, Fabra, NF, Colina, NR, Rodriguez-Vico, JS, Salgado, MR, García, NG, Urabayen, AE, Vendrell, AM, Lázaro, IF, del Rincón, CR, Pérez, RL, Layos-Romero, A, Nieto, RB, Osorio, YG, Guisado-Alonso, D, Durán, AO, López, JT, González-Fernández, L, Fernández-Fernández, S, Rodriguez, HM, García, AG, Díaz, SC, Gutierrez, SQ, Rodriguez, NS, Sánchez, MTS, Galindo, TM, Peña, SF, dela Cadiniere, MDLI, Martínez, AG, Azorín, DG. MADRE MIA: Monoclonal Antibody Duration of REsponse in MIgraine After treatment interruption: A prospective multicentric study on 2164 patients. JOURNAL OF HEADACHE AND PAIN. 2024; 25DOI:. PMID:. IF:7.900(Q1/1D).

Nieto, RB, Láinez, MJ, Huth, M, Francis, P, Singh, S, McMaster, A, Hasham, SN, Suthar, B, Srivastava, PK. The comparative safety and efficacy of anti-migraine medications and devices in migraine prophylaxis: a network meta-analysis. JOURNAL OF HEADACHE AND PAIN. 2024; 25DOI:. PMID:. IF:7.900(Q1/1D).

Martínez, AG, del Rincón, CR, Gutierrez, SQ, Azorín, DG, Lázaro, IF, Peral, ALG, Osorio, YG, Díez, FI, Iñiguez, AE, Luque, SG, Villanueva, MH, Díaz, SC, Vendrell, AM, Juanes, FV, Ros, AL, Soblechero, AS, Sánchez-Mateos, NM, Belvis, R, Zubizarreta, IK, Urabayen, AE, Rodrígue-Vico, JS, Sanchez, AJ, García, AG, Pérez, MPN, Montes, N, Gago-Viega, A. RE-START STUDY: Multicenter study to assess response after reintroduction of anti-CGRP antibodies in patients with migraine. JOURNAL OF HEADACHE AND PAIN. 2024; 25DOI:. PMID:. IF:7.900(Q1/1D).